Literature DB >> 7196477

[Combination chemotherapy with cis-dichloro-diammineplatinum (II) and ifosfamide in malignant melanomas (author's transl)].

B R Balda, U Jehn, W Klövekorn, A Wohlrab.   

Abstract

We report our results on 9 patients with disseminated malignant melanoma, treated with combination of DDP and IF, 3 in addition with VD. In none of them a complete remission was obtained, the median survival was 4.2 months. These disappointing results, in addition to the rather toxic side effects from the chemotherapy, do not present any benefit over less toxic regimens.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7196477     DOI： 10.1007/bf01724683

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  7 in total

1.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

2.  [Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].

Authors:  W E Berdel; U Fink; B Emmerich; P A Maubach; U Busch; W Remy; J Rastetter
Journal:  Dtsch Med Wochenschr       Date:  1982-01-08       Impact factor: 0.628

3.  Vindesine as a single agent in the treatment of advanced malignant melanoma.

Authors:  S Retsas; K A Newton; G Westbury
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.

Authors:  R Becher; S Seeber; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

5.  Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination.

Authors:  R E Wittes; J T Wittes; R B Golbey
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

6.  [Combined chemotherapy of metastasing melanoblastoma using ifosfamide and cis-platinum (II)-diamminodichloride (author's transl)].

Authors:  C G Schmidt; R Becher
Journal:  Dtsch Med Wochenschr       Date:  1979-06-15       Impact factor: 0.628

7.  Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanoma.

Authors:  J E Goodnight; H S Moseley; F R Eilber; G Sarna; D L Morton
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.